Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers
NCT01181063
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Budesonide/formoterol 320/9 μg and 400/12 μg inhalers
Sponsor
Orion Corporation, Orion Pharma